Skip to main content
Caplight Logo









Womed

Womed

Private
MontpellierHealthcare & Life Scienceshttps://womedtech.com

Last Round

VC Round

Jun 30, 2026

Est. Valuation

$37.32M

Total Funding Raised

$10.35M

Company Overview

Womed operates in Healthcare & Life Sciences and is based in Montpellier. Its latest recorded funding round was a VC Round in June 2026.

Womed is a women's health company that develops intrauterine therapies based on a proprietary, biodegradable polymer technology platform for treating uterine pathologies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Womed Comparables

Compare Womed with similar companies based on industry and business-model similarity.

Womed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Johnson & Johnson
78%
Rejoni, Inc.
74%
ARC Medical Inc.
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Womed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 30, 2026
GrantMay 1, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Gonzague Issenmann

Executive Chairman and CEO

Executive Team

For institutional investors. Book with your work email.

Womed Investors

Notable investors and investment history

Womed investors
InvestorRounds
European Innovation Council FundGrant
IRDI Soridec GestionSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 6, 2026

    Monthly visitors increased 73% MoM.

  • Jan 4, 2026

    Monthly visitors grew 49% MoM, from 908 to 1.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Womed Filings

Explore SEC and related filing metadata, where available.

Womed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Womed's valuation, stock price, and market status.

Is Womed a public or private company?

Womed is a private company.

What is the current stock price of Womed?

Womed is a private company, so its shares have no public market price. Caplight tracks Womed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Womed worth (valuation)?

Womed's valuation is estimated at $37.3M based on funding round data.

Can I buy Womed stock?

Womed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Womed's last funding round?

Womed's most recent funding round was VC Round on June 30, 2026.

Who are the main investors in Womed?

Key investors in Womed include European Innovation Council Fund, IRDI Soridec Gestion.

Will Womed IPO soon?

No public IPO plans have been announced for Womed.

How can I track Womed secondary market activity?

Caplight tracks bids, offers, and trades in Womed's shares on secondary markets.

Firmographic Details

HeadquartersMontpellier
Employee Range16
Year Founded2018
Last FundingJun 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?